Here's the Major Earnings Before the Open Tomorrow

Seeking Alpha07:00

Insights Ahead: Royalty Pharma's Quarterly Earnings

Benzinga11/05 22:02

Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo

PRNewswire11/05 05:01

Press Release: Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo(TM)

Dow Jones11/05 05:01

Royalty Pharma Plc (NASDAQ:RPRX) Is a Favorite Amongst Institutional Investors Who Own 72%

Simply Wall St11/04 23:48

Bristol Myers Posts Long-term Phase 3 Data for Schizophrenia Drug Cobenfy

Seeking Alpha11/01 22:46